孕期糖尿病通过破坏GABAergic系统,诱导后代的自闭症类行为
Xuan-Qi Liu1, Tian-Li Huang1, Shu-Yu Zhang2
1The Key Laboratory of Reproductive Genetics (Zhejiang University), Ministry of Education, Zhejiang University School of Medicine, Hangzhou, China.
Frontiers in neuroscience
|February 27, 2025
概括
母亲的孕期糖尿病 (GDM) 与男性后代的自闭症行为有关,其特点是社会新性受损和刻板印象行为增加. 这是由于大脑GABAergic系统的改变.
科学领域:
- 神经科学是一个神经科学.
- 发展生物学 发展生物学
- 代谢学 代谢学 代谢学
背景情况:
- 孕期糖尿病 (GDM) 越来越多地与后代的自闭症风险有关.
- 这种关联背后的精确生物机制尚不清楚.
研究的目的:
- 用小鼠模型研究GDM对后代神经发育和行为的影响.
- 阐明神经生物学机制,特别是涉及GABAergic系统,通过GDM影响后代.
主要方法:
- 建立了一个GDM的小鼠模型.
- 对社会新和刻板印象行为进行行为分析.
- 通过c-Fos染色评估前额叶皮层 (PFC) 神经元刺激性.
- 利用单细胞转录学和代谢学来分析GABAergic系统.
主要成果:
- GDM后代表现出减少的社会新奇性和增加的刻板印象行为.
- 来自GDM母亲的男性后代显示PFC过度兴奋.
- 在GDM后代中确定了减少的GABAergic神经元和降低的GABA水平.
- 观察到与GAD2促进体DNA高甲基化相关的GAD2表达的减少.
结论:
- 通过破坏GABAergic系统,GDM会诱导后代的自闭症类行为.
- 这些发现为GDM对神经发育和自闭症风险的影响提供了新的见解.
相关概念视频
Pathophysiology of Diabetes
842
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
842
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Inborn Errors of Metabolism
122
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
122
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Glucose Transporters
22.4K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.4K
Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K


